Ceasefire Nears Collapse as Iran Threatens Strikes on Northern Israel

Lilly's Next-Gen Weight-Loss Drug Clears Trial With Near-Bariatric Surgery Results Eli Lilly reported positive Phase 3 results for its next-generation obesity drug, retatrutide, which delivered weight-loss results on par with those of bariatric surgery. In the TRIUMPH-1 trial, overweight adults, but without diabetes, achieved meaningful weight loss across all tested doses after 80 weeks: 12 mg dose: average weight loss of 70.3 pounds, or 28.3% of body weight. 9 mg dose: average weight loss of 64.4 pounds, or 25.9%. 4 mg dose: average weight loss of 47.2 pounds, or 19% Ahead of the results,...

Here's What Happened Inside Convenience Stores When Gas Hit $4 Continuing our coverage of consumer behavior shifts at petrol stations and convenience stores, the U.S. national average for 87-octane gasoline has remained above the politically sensitive $4-a-gallon level for three weeks. Goldman analysts have released a new note indicating that a majority of convenience stores are seeing drivers buying less fuel and trading down in-store. Bonnie Herzog, managing director and senior consumer analyst at Goldman, penned a note titled Q1 "Beverage Bytes," which covers a survey of 32,000 retail locations, or...